The press releases contained in this section of the website are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. Amarin disavows any obligation to update the information contained in such press releases after the date of their issuance.
Dublin, Ireland and Mystic, CT, USA , April 27, 2010 – Amarin Corporation plc (NASDAQ: AMRN) today announced that John Thero, Chief Financial Officer, is scheduled to present at Deutsche Bank Securities 35th Annual Health Care Conference.The presentation will be made on Monday, May 3, 2010 at 2:50
DUBLIN and MYSTIC, Conn., March 3 /PRNewswire-FirstCall/ --Amarin Corporation plc (Nasdaq: AMRN - News ) today announced that John F. Thero, Chief Financial Officer, is scheduled to present at Cowen and Company's 30th Annual Healthcare Conference on Wednesday, March 10, 2010 at 8:45 am Eastern
DUBLIN and MYSTIC, Conn, Feb. 11 -- Amarin Corporation plc (Nasdaq: AMRN), a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease, is pleased to announce the appointment of Mr. Jan van Heek to its board of directors as a non-executive director.
DUBLIN and MYSTIC, Conn., Feb. 2 /PRNewswire-FirstCall/ -- Amarin Corporation plc (Nasdaq: AMRN ) today announced that Dr. Declan Doogan, Interim Chief Executive Officer, is scheduled to present at the 12th Annual BIO CEO & Investor Conference on Monday, February 8th at 10:30am Eastern Time.
DUBLIN, Ireland, November 23, 2009 – Amarin Corporation plc (NASDAQ: AMRN) announced today that it has sent to its shareholders a Notice of the Annual General Meeting of the Company, which will be held on December 21, 2009 in Dublin, Ireland. Copies of the Notice, together with the Company’s Annual
AMARIN CORP IS FIRST SMALL BIOPHARMACEUTICAL COMPANY TO JOIN SAFE-BIOPHARMA ASSOCIATION Ft. Lee, N.J. (November 11, 2009) – Amarin Corp .(NASDAQ: AMRN), a clinical stage pharmaceutical company with R&D operations based in Mystic, Conn., has joined SAFE-BioPharma Association , the non-profit
AMARIN APPOINTS JOHN F. THERO AS CHIEF FINANCIAL OFFICER DUBLIN, Ireland, November 6th, 2009 – Amarin Corporation plc (NASDAQ: AMRN) today announced the appointment of John F. Thero as the Company’s Chief Financial Officer. In this role, Mr. Thero will have broad responsibility for financial and